{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "e10466cc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['compliance_agent',\n",
       " 'parallel_analyzer_agent',\n",
       " 'search_agent',\n",
       " 'sequential_analyzer_agent',\n",
       " 'simple_prescription_agent']"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import requests\n",
    "import json\n",
    "import uuid\n",
    "\n",
    "# Configuração\n",
    "BASE_URL_ADK_SERVER = \"https://adk-server-health-894271896157.europe-west1.run.app\"\n",
    "BASE_URL_FASTAPI = \"https://fastapi-server-health-894271896157.europe-west1.run.app\"\n",
    "\n",
    "\n",
    "def get_all_apps(base_url=BASE_URL_ADK_SERVER):\n",
    "    \"\"\"\n",
    "    Recupera a lista de todos os aplicativos disponíveis na API ADK.\n",
    "    \n",
    "    Returns:\n",
    "        list - Lista de aplicativos.\n",
    "    \"\"\"\n",
    "    response = requests.get(f\"{base_url}/list-apps\")\n",
    "    return response.json()\n",
    "\n",
    "all_apps = get_all_apps()\n",
    "all_apps"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "cbf0086b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load data \n",
    "with open(\"../data/patients_ready_to_dashboard.json\", \"r\", encoding=\"utf-8\") as f:\n",
    "    df_ready_to_dashboard = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "3ca7855a",
   "metadata": {},
   "outputs": [],
   "source": [
    "sample = df_ready_to_dashboard[:10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "ea552d2b",
   "metadata": {},
   "outputs": [],
   "source": [
    "inputs_to_llm = [patient['admission_str_input_to_llm'] for patient in sample]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "b47abfe9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\"Subject ID: 0\\nAdmission ID: 169938\\nAdmission Date: 4323585540000\\nDischarge Date: 4324203900000\\nInsurance: Medicare\\nAge: None\\nGender: M\\nLanguage: None\\nMarital Status: UNKNOWN (DEFAULT)\\nEthnicity: WHITE\\nCreatinine: 1.1 mg/dL\\nHemoglobin: 10.0 g/dL\\nPotassium: 3.7 mEq/L\\nSodium: 142.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: SW, Type: BASE, Dose: 100 ml, Form: None, Route: IV, Start: 2107-01-06 00:00:00, Stop: 2107-01-07 00:00:00--------------------------------\\n  - Drug: NS, Type: BASE, Dose: 500 ml, Form: None, Route: IV, Start: 2107-01-06 00:00:00, Stop: 2107-01-07 00:00:00--------------------------------\\n  - Drug: NS, Type: BASE, Dose: 500 ml, Form: None, Route: IV, Start: 2107-01-06 00:00:00, Stop: 2107-01-07 00:00:00--------------------------------\\n  - Drug: Iso-Osmotic Dextrose, Type: BASE, Dose: 200 ml, Form: None, Route: IV, Start: 2107-01-07 00:00:00, Stop: 2107-01-08 00:00:00--------------------------------\\n  - Drug: Fat Emulsion 20%, Type: BASE, Dose: 250 ml, Form: None, Route: IV, Start: 2107-01-07 00:00:00, Stop: 2107-01-11 00:00:00--------------------------------\\n  - Drug: SW, Type: BASE, Dose: 100 ml, Form: None, Route: IV, Start: 2107-01-08 00:00:00, Stop: 2107-01-08 00:00:00--------------------------------\\n  - Drug: Amino Acids 4.25% W/ Dextrose 5%, Type: BASE, Dose: 1000 ml, Form: None, Route: IV, Start: 2107-01-08 00:00:00, Stop: 2107-01-08 00:00:00--------------------------------\\n  - Drug: Amino Acids 4.25% W/ Dextrose 5%, Type: BASE, Dose: 1000 ml, Form: None, Route: IV, Start: 2107-01-08 00:00:00, Stop: 2107-01-09 00:00:00--------------------------------\\n  - Drug: NS, Type: BASE, Dose: 100 ml, Form: None, Route: IV, Start: 2107-01-09 00:00:00, Stop: 2107-01-10 00:00:00--------------------------------\\n  - Drug: D5W, Type: BASE, Dose: 50 ml, Form: None, Route: IV, Start: 2107-01-09 00:00:00, Stop: 2107-01-09 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'MethylPREDNISolone Sodium Succ', 'drug_type': 'BASE', 'dose_val': '1500-2900', 'dose_unit': 'mg', 'form': None, 'route': 'SC', 'starttime': '2107-01-10 00:00:00', 'stoptime': '2107-01-11 00:00:00'}\",\n",
       " \"Subject ID: 1\\nAdmission ID: 180546\\nAdmission Date: 7301011740000\\nDischarge Date: 7301628240000\\nInsurance: Medicare\\nAge: None\\nGender: M\\nLanguage: SPAN\\nMarital Status: MARRIED\\nEthnicity: HISPANIC/LATINO - PUERTO RICAN\\nCreatinine: 0.4 mg/dL\\nHemoglobin: 9.4 g/dL\\nPotassium: 3.4 mEq/L\\nSodium: 137.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Albuterol 0.083% Neb Soln, Type: MAIN, Dose: 1 NEB, Form: None, Route: IH, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Ipratropium Bromide Neb, Type: MAIN, Dose: 1 NEB, Form: None, Route: IH, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Docusate Sodium, Type: MAIN, Dose: 200 mg, Form: None, Route: PO, Start: 2201-05-12 00:00:00, Stop: 2201-05-12 00:00:00--------------------------------\\n  - Drug: Dextrose 50%, Type: MAIN, Dose: 12.5 gm, Form: None, Route: IV, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Glucagon, Type: MAIN, Dose: 1 mg, Form: None, Route: IM, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Miconazole Powder 2%, Type: MAIN, Dose: 1 Appl, Form: None, Route: TP, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Ascorbic Acid, Type: MAIN, Dose: 500 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-15 00:00:00--------------------------------\\n  - Drug: Lansoprazole Oral Disintegrating Tab, Type: MAIN, Dose: 30 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Zinc Sulfate, Type: MAIN, Dose: 220 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Baclofen, Type: MAIN, Dose: 15 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-14 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Mycophenolate Mofetil', 'drug_type': 'MAIN', 'dose_val': '3000', 'dose_unit': 'Enema', 'form': None, 'route': 'ORAL', 'starttime': '2201-05-12 00:00:00', 'stoptime': '2201-05-19 00:00:00'}\",\n",
       " \"Subject ID: 2\\nAdmission ID: 198330\\nAdmission Date: 4493893500000\\nDischarge Date: 4494761400000\\nInsurance: Private\\nAge: None\\nGender: M\\nLanguage: ENGL\\nMarital Status: SINGLE\\nEthnicity: WHITE\\nCreatinine: 0.6 mg/dL\\nHemoglobin: 8.8 g/dL\\nPotassium: 4.1 mEq/L\\nSodium: 138.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Potassium Chloride, Type: MAIN, Dose: 40 mEq, Form: None, Route: PO, Start: 2112-05-29 00:00:00, Stop: 2112-05-30 00:00:00--------------------------------\\n  - Drug: Heparin Flush (10 units/ml), Type: MAIN, Dose: 10 mL, Form: None, Route: IV, Start: 2112-05-29 00:00:00, Stop: 2112-05-31 00:00:00--------------------------------\\n  - Drug: Morphine Sulfate, Type: MAIN, Dose: 2-4 mg, Form: None, Route: IV, Start: 2112-05-29 00:00:00, Stop: 2112-05-30 00:00:00--------------------------------\\n  - Drug: Morphine Sulfate, Type: MAIN, Dose: 2-4 mg, Form: None, Route: IV, Start: 2112-05-29 00:00:00, Stop: 2112-05-30 00:00:00--------------------------------\\n  - Drug: Docusate Sodium, Type: MAIN, Dose: 100 mg, Form: None, Route: PO, Start: 2112-05-29 00:00:00, Stop: 2112-06-07 00:00:00--------------------------------\\n  - Drug: Sodium Chloride 0.9%  Flush, Type: MAIN, Dose: 3 mL, Form: None, Route: IV, Start: 2112-05-30 00:00:00, Stop: 2112-05-30 00:00:00--------------------------------\\n  - Drug: Ketorolac, Type: MAIN, Dose: 15 mg, Form: None, Route: IV, Start: 2112-05-30 00:00:00, Stop: 2112-05-30 00:00:00--------------------------------\\n  - Drug: HYDROmorphone (Dilaudid), Type: MAIN, Dose: 12.5 mg, Form: None, Route: IVPCA, Start: 2112-05-30 00:00:00, Stop: 2112-06-01 00:00:00--------------------------------\\n  - Drug: Ondansetron, Type: MAIN, Dose: 4 mg, Form: None, Route: IV, Start: 2112-05-30 00:00:00, Stop: 2112-06-07 00:00:00--------------------------------\\n  - Drug: Ketorolac, Type: MAIN, Dose: 30 mg, Form: None, Route: IV, Start: 2112-05-30 00:00:00, Stop: 2112-05-31 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Carbidopa-Levodopa (10-100)', 'drug_type': 'ADDITIVE', 'dose_val': '1800-3600', 'dose_unit': 'mcg', 'form': None, 'route': 'RIGHT EYE', 'starttime': '2112-05-30 00:00:00', 'stoptime': '2112-05-31 00:00:00'}\",\n",
       " \"Subject ID: 3\\nAdmission ID: 139932\\nAdmission Date: 5609405400000\\nDischarge Date: 5612182200000\\nInsurance: Medicare\\nAge: None\\nGender: F\\nLanguage: ENGL\\nMarital Status: MARRIED\\nEthnicity: WHITE\\nCreatinine: 0.5 mg/dL\\nHemoglobin: 9.4 g/dL\\nPotassium: 3.5 mEq/L\\nSodium: 143.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: PHENObarbital, Type: MAIN, Dose: 1000 mg, Form: None, Route: IV, Start: 2147-10-17 00:00:00, Stop: 2147-10-18 00:00:00--------------------------------\\n  - Drug: Fosphenytoin, Type: MAIN, Dose: 500 mg PE, Form: None, Route: IV, Start: 2147-10-18 00:00:00, Stop: 2147-10-19 00:00:00--------------------------------\\n  - Drug: Calcium Gluconate, Type: MAIN, Dose: 4 gm, Form: None, Route: IV, Start: 2147-10-18 00:00:00, Stop: 2147-10-31 00:00:00--------------------------------\\n  - Drug: Vancomycin, Type: MAIN, Dose: 750 mg, Form: None, Route: IV, Start: 2147-10-19 00:00:00, Stop: 2147-10-20 00:00:00--------------------------------\\n  - Drug: Fosphenytoin, Type: MAIN, Dose: 600 mg PE, Form: None, Route: IV, Start: 2147-10-19 00:00:00, Stop: 2147-10-20 00:00:00--------------------------------\\n  - Drug: Fosphenytoin, Type: MAIN, Dose: 200 mg PE, Form: None, Route: IV, Start: 2147-10-19 00:00:00, Stop: 2147-10-31 00:00:00--------------------------------\\n  - Drug: Morphine Sulfate, Type: MAIN, Dose: 100 mg, Form: None, Route: IV DRIP, Start: 2147-10-31 00:00:00, Stop: 2147-10-31 00:00:00--------------------------------\\n  - Drug: Morphine Sulfate, Type: MAIN, Dose: 100 mg, Form: None, Route: IV DRIP, Start: 2147-10-31 00:00:00, Stop: 2147-11-03 00:00:00--------------------------------\\n  - Drug: PHENObarbital, Type: MAIN, Dose: 300 mg, Form: None, Route: IV, Start: 2147-11-02 00:00:00, Stop: 2147-11-02 00:00:00--------------------------------\\n  - Drug: Morphine Sulfate, Type: MAIN, Dose: 100 mg, Form: None, Route: IV DRIP, Start: 2147-11-03 00:00:00, Stop: 2147-11-04 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Rituximab', 'drug_type': 'BASE', 'dose_val': '100', 'dose_unit': 'Appl', 'form': None, 'route': 'OU', 'starttime': '2147-11-04 00:00:00', 'stoptime': '2147-11-05 00:00:00'}\",\n",
       " \"Subject ID: 4\\nAdmission ID: 171628\\nAdmission Date: 4484040540000\\nDischarge Date: 4484635200000\\nInsurance: Private\\nAge: None\\nGender: M\\nLanguage: ENGL\\nMarital Status: SINGLE\\nEthnicity: WHITE\\nCreatinine: 0.6 mg/dL\\nHemoglobin: 10.1 g/dL\\nPotassium: 4.3 mEq/L\\nSodium: 135.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Lorazepam, Type: MAIN, Dose: 0.25-2 mg, Form: None, Route: IV, Start: 2112-02-04 00:00:00, Stop: 2112-02-08 00:00:00--------------------------------\\n  - Drug: Propofol, Type: MAIN, Dose: 1000 mg, Form: None, Route: IV DRIP, Start: 2112-02-06 00:00:00, Stop: 2112-02-06 00:00:00--------------------------------\\n  - Drug: Propofol, Type: MAIN, Dose: 200 mg, Form: None, Route: IV DRIP, Start: 2112-02-06 00:00:00, Stop: 2112-02-06 00:00:00--------------------------------\\n  - Drug: Morphine Sulfate, Type: MAIN, Dose: 1-2 mg, Form: None, Route: IV, Start: 2112-02-06 00:00:00, Stop: 2112-02-08 00:00:00--------------------------------\\n  - Drug: Midazolam, Type: MAIN, Dose: 0.5 mg, Form: None, Route: IV, Start: 2112-02-06 00:00:00, Stop: 2112-02-08 00:00:00--------------------------------\\n  - Drug: Vancomycin, Type: MAIN, Dose: 750 mg, Form: None, Route: IV, Start: 2112-02-07 00:00:00, Stop: 2112-02-07 00:00:00--------------------------------\\n  - Drug: DiphenhydrAMINE, Type: MAIN, Dose: 12.5 mg, Form: None, Route: IV, Start: 2112-02-08 00:00:00, Stop: 2112-02-09 00:00:00--------------------------------\\n  - Drug: Midazolam, Type: MAIN, Dose: 1 mg, Form: None, Route: IV, Start: 2112-02-08 00:00:00, Stop: 2112-02-09 00:00:00--------------------------------\\n  - Drug: Fentanyl Citrate, Type: MAIN, Dose: 25-100 mcg, Form: None, Route: IV, Start: 2112-02-08 00:00:00, Stop: 2112-02-09 00:00:00--------------------------------\\n  - Drug: Midazolam, Type: MAIN, Dose: 1 mg, Form: None, Route: IV, Start: 2112-02-08 00:00:00, Stop: 2112-02-09 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Nafcillin', 'drug_type': 'ADDITIVE', 'dose_val': '1334', 'dose_unit': 'AMP', 'form': None, 'route': 'NU', 'starttime': '2112-02-08 00:00:00', 'stoptime': '2112-02-09 00:00:00'}\",\n",
       " \"Subject ID: 5\\nAdmission ID: 180391\\nAdmission Date: 6026104020000\\nDischarge Date: 6026542200000\\nInsurance: Medicare\\nAge: None\\nGender: F\\nLanguage: ENGL\\nMarital Status: SINGLE\\nEthnicity: WHITE\\nCreatinine: 0.6 mg/dL\\nHemoglobin: 12.3 g/dL\\nPotassium: 3.6 mEq/L\\nSodium: 142.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Senna, Type: MAIN, Dose: 1 TAB, Form: None, Route: PO, Start: 2160-12-20 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Potassium Chloride, Type: MAIN, Dose: 60 mEq, Form: None, Route: PO, Start: 2160-12-20 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Polyethylene Glycol, Type: MAIN, Dose: 17 g, Form: None, Route: PO, Start: 2160-12-20 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Potassium Chloride, Type: MAIN, Dose: 20 mEq, Form: None, Route: PO, Start: 2160-12-21 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Potassium Chloride, Type: MAIN, Dose: 40 mEq, Form: None, Route: PO, Start: 2160-12-21 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Iso-Osmotic Dextrose, Type: BASE, Dose: 50 mL, Form: None, Route: IV, Start: 2160-12-17 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Iso-Osmotic Dextrose, Type: BASE, Dose: 200 mL, Form: None, Route: IV, Start: 2160-12-17 00:00:00, Stop: 2160-12-17 00:00:00--------------------------------\\n  - Drug: 5% Dextrose, Type: BASE, Dose: 500 mL, Form: None, Route: IV, Start: 2160-12-20 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: CeftriaXONE, Type: MAIN, Dose: 1 g, Form: None, Route: IV, Start: 2160-12-17 00:00:00, Stop: 2160-12-21 00:00:00--------------------------------\\n  - Drug: Vancomycin, Type: MAIN, Dose: 1000 mg, Form: None, Route: IV, Start: 2160-12-17 00:00:00, Stop: 2160-12-17 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Ciprofloxacin', 'drug_type': 'MAIN', 'dose_val': '98', 'dose_unit': 'Enema', 'form': None, 'route': 'PO', 'starttime': '2160-12-20 00:00:00', 'stoptime': '2160-12-21 00:00:00'}\",\n",
       " \"Subject ID: 6\\nAdmission ID: 180546\\nAdmission Date: 7301011740000\\nDischarge Date: 7301628240000\\nInsurance: Medicare\\nAge: None\\nGender: M\\nLanguage: SPAN\\nMarital Status: MARRIED\\nEthnicity: HISPANIC/LATINO - PUERTO RICAN\\nCreatinine: 0.4 mg/dL\\nHemoglobin: 9.4 g/dL\\nPotassium: 3.4 mEq/L\\nSodium: 137.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Albuterol 0.083% Neb Soln, Type: MAIN, Dose: 1 NEB, Form: None, Route: IH, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Ipratropium Bromide Neb, Type: MAIN, Dose: 1 NEB, Form: None, Route: IH, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Docusate Sodium, Type: MAIN, Dose: 200 mg, Form: None, Route: PO, Start: 2201-05-12 00:00:00, Stop: 2201-05-12 00:00:00--------------------------------\\n  - Drug: Dextrose 50%, Type: MAIN, Dose: 12.5 gm, Form: None, Route: IV, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Glucagon, Type: MAIN, Dose: 1 mg, Form: None, Route: IM, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Miconazole Powder 2%, Type: MAIN, Dose: 1 Appl, Form: None, Route: TP, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Ascorbic Acid, Type: MAIN, Dose: 500 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-15 00:00:00--------------------------------\\n  - Drug: Lansoprazole Oral Disintegrating Tab, Type: MAIN, Dose: 30 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Zinc Sulfate, Type: MAIN, Dose: 220 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Baclofen, Type: MAIN, Dose: 15 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-14 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Mycophenolate Mofetil', 'drug_type': 'MAIN', 'dose_val': '3000', 'dose_unit': 'Enema', 'form': None, 'route': 'ORAL', 'starttime': '2201-05-12 00:00:00', 'stoptime': '2201-05-19 00:00:00'}\",\n",
       " \"Subject ID: 7\\nAdmission ID: 180546\\nAdmission Date: 7301011740000\\nDischarge Date: 7301628240000\\nInsurance: Medicare\\nAge: None\\nGender: M\\nLanguage: SPAN\\nMarital Status: MARRIED\\nEthnicity: HISPANIC/LATINO - PUERTO RICAN\\nCreatinine: 0.4 mg/dL\\nHemoglobin: 9.4 g/dL\\nPotassium: 3.4 mEq/L\\nSodium: 137.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Albuterol 0.083% Neb Soln, Type: MAIN, Dose: 1 NEB, Form: None, Route: IH, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Ipratropium Bromide Neb, Type: MAIN, Dose: 1 NEB, Form: None, Route: IH, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Docusate Sodium, Type: MAIN, Dose: 200 mg, Form: None, Route: PO, Start: 2201-05-12 00:00:00, Stop: 2201-05-12 00:00:00--------------------------------\\n  - Drug: Dextrose 50%, Type: MAIN, Dose: 12.5 gm, Form: None, Route: IV, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Glucagon, Type: MAIN, Dose: 1 mg, Form: None, Route: IM, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Miconazole Powder 2%, Type: MAIN, Dose: 1 Appl, Form: None, Route: TP, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Ascorbic Acid, Type: MAIN, Dose: 500 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-15 00:00:00--------------------------------\\n  - Drug: Lansoprazole Oral Disintegrating Tab, Type: MAIN, Dose: 30 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Zinc Sulfate, Type: MAIN, Dose: 220 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-19 00:00:00--------------------------------\\n  - Drug: Baclofen, Type: MAIN, Dose: 15 mg, Form: None, Route: PO/NG, Start: 2201-05-12 00:00:00, Stop: 2201-05-14 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Mycophenolate Mofetil', 'drug_type': 'MAIN', 'dose_val': '3000', 'dose_unit': 'Enema', 'form': None, 'route': 'ORAL', 'starttime': '2201-05-12 00:00:00', 'stoptime': '2201-05-19 00:00:00'}\",\n",
       " \"Subject ID: 8\\nAdmission ID: 142539\\nAdmission Date: 4993033020000\\nDischarge Date: 4993210800000\\nInsurance: Government\\nAge: None\\nGender: M\\nLanguage: None\\nMarital Status: MARRIED\\nEthnicity: WHITE\\nCreatinine: 0.9 mg/dL\\nHemoglobin: 13.2 g/dL\\nPotassium: 5.2 mEq/L\\nSodium: 133.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Lorazepam, Type: MAIN, Dose: 0.5 mg, Form: None, Route: PO, Start: 2128-03-24 00:00:00, Stop: 2128-03-25 00:00:00--------------------------------\\n  - Drug: HYDROmorphone (Dilaudid), Type: MAIN, Dose: 2 mg, Form: None, Route: IV, Start: 2128-03-24 00:00:00, Stop: 2128-03-25 00:00:00--------------------------------\\n  - Drug: Simethicone, Type: MAIN, Dose: 40-80 mg, Form: None, Route: PO, Start: 2128-03-24 00:00:00, Stop: 2128-03-24 00:00:00--------------------------------\\n  - Drug: HYDROmorphone (Dilaudid), Type: MAIN, Dose: 2 mg, Form: None, Route: IV, Start: 2128-03-24 00:00:00, Stop: 2128-03-25 00:00:00--------------------------------\\n  - Drug: HYDROmorphone (Dilaudid), Type: MAIN, Dose: 0 mg, Form: None, Route: IVPCA, Start: 2128-03-24 00:00:00, Stop: 2128-03-25 00:00:00--------------------------------\\n  - Drug: NS, Type: BASE, Dose: 1000 ml, Form: None, Route: IV, Start: 2128-03-22 00:00:00, Stop: 2128-03-23 00:00:00--------------------------------\\n  - Drug: NS, Type: BASE, Dose: 1000 ml, Form: None, Route: IV, Start: 2128-03-22 00:00:00, Stop: 2128-03-23 00:00:00--------------------------------\\n  - Drug: Vial, Type: BASE, Dose: 1 VIAL, Form: None, Route: IV, Start: 2128-03-24 00:00:00, Stop: 2128-03-24 00:00:00--------------------------------\\n  - Drug: D5W, Type: BASE, Dose: 100 ml, Form: None, Route: IV DRIP, Start: 2128-03-24 00:00:00, Stop: 2128-03-24 00:00:00--------------------------------\\n  - Drug: Pantoprazole Sodium, Type: MAIN, Dose: 40 mg, Form: None, Route: IV, Start: 2128-03-24 00:00:00, Stop: 2128-03-24 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Bacitracin Ointment', 'drug_type': 'MAIN', 'dose_val': '700', 'dose_unit': 'dose', 'form': None, 'route': 'DIALYS', 'starttime': '2128-03-24 00:00:00', 'stoptime': '2128-03-24 00:00:00'}\",\n",
       " \"Subject ID: 9\\nAdmission ID: 199395\\nAdmission Date: 6959286900000\\nDischarge Date: 6960348000000\\nInsurance: Medicare\\nAge: None\\nGender: F\\nLanguage: None\\nMarital Status: MARRIED\\nEthnicity: WHITE\\nCreatinine: 2.3 mg/dL\\nHemoglobin: 11.0 g/dL\\nPotassium: 4.6 mEq/L\\nSodium: 143.0 mEq/L\\nNotes (24h Summary): None\\nPrescriptions:   - Drug: Oxycodone-Acetaminophen, Type: MAIN, Dose: 1-2 TAB, Form: None, Route: PO, Start: 2190-07-16 00:00:00, Stop: 2190-07-18 00:00:00--------------------------------\\n  - Drug: Oxycodone-Acetaminophen, Type: MAIN, Dose: 5-10 ml, Form: None, Route: PO, Start: 2190-07-16 00:00:00, Stop: 2190-07-18 00:00:00--------------------------------\\n  - Drug: Amiodarone HCl, Type: MAIN, Dose: 150 mg, Form: None, Route: IV, Start: 2190-07-17 00:00:00, Stop: 2190-07-18 00:00:00--------------------------------\\n  - Drug: GlipiZIDE, Type: MAIN, Dose: 7.5 mg, Form: None, Route: PO, Start: 2190-07-17 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\\n  - Drug: Amiodarone HCl, Type: MAIN, Dose: 400 mg, Form: None, Route: PO, Start: 2190-07-18 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\\n  - Drug: Potassium Chloride, Type: MAIN, Dose: 20 mEq, Form: None, Route: PO, Start: 2190-07-18 00:00:00, Stop: 2190-07-19 00:00:00--------------------------------\\n  - Drug: Oxycodone-Acetaminophen, Type: MAIN, Dose: 1-2 TAB, Form: None, Route: PO, Start: 2190-07-19 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\\n  - Drug: Amiodarone HCl, Type: MAIN, Dose: 150 mg, Form: None, Route: IV, Start: 2190-07-19 00:00:00, Stop: 2190-07-20 00:00:00--------------------------------\\n  - Drug: Magnesium Sulfate, Type: MAIN, Dose: 2 gm, Form: None, Route: IV, Start: 2190-07-19 00:00:00, Stop: 2190-07-20 00:00:00--------------------------------\\n  - Drug: Metoprolol, Type: MAIN, Dose: 12.5 mg, Form: None, Route: PO, Start: 2190-07-20 00:00:00, Stop: 2190-07-21 00:00:00--------------------------------\\n----------------------------------------\\n\\n-------\\nCurrent Prescription: {'drug': 'Fentanyl Patch', 'drug_type': 'MAIN', 'dose_val': '225', 'dose_unit': 'PUFF', 'form': None, 'route': 'DWELL', 'starttime': '2190-07-20 00:00:00', 'stoptime': '2190-07-25 00:00:00'}\"]"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "inputs_to_llm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "a45b43cf",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "API wrapper functions loaded:\n",
      "- analyze_simple(health_data)\n",
      "- analyze_parallel(health_data)\n",
      "- analyze_sequential(health_data)\n",
      "- analyze_all(health_data)\n"
     ]
    }
   ],
   "source": [
    "# Simple API wrapper functions\n",
    "def analyze_simple(health_data: str):\n",
    "    \"\"\"Simple prescription analysis\"\"\"\n",
    "    response = requests.post(\n",
    "        f\"{BASE_URL_FASTAPI}/analyze/simple\",\n",
    "        json={\"health_data\": health_data}\n",
    "    )\n",
    "    return response.json()\n",
    "\n",
    "def analyze_parallel(health_data: str):\n",
    "    \"\"\"Parallel multi-agent analysis\"\"\"\n",
    "    response = requests.post(\n",
    "        f\"{BASE_URL_FASTAPI}/analyze/parallel\", \n",
    "        json={\"health_data\": health_data}\n",
    "    )\n",
    "    return response.json()\n",
    "\n",
    "def analyze_sequential(health_data: str):\n",
    "    \"\"\"Sequential health analysis\"\"\"\n",
    "    response = requests.post(\n",
    "        f\"{BASE_URL_FASTAPI}/analyze/sequential\",\n",
    "        json={\"health_data\": health_data}\n",
    "    )\n",
    "    return response.json()\n",
    "\n",
    "def analyze_all(health_data: str):\n",
    "    \"\"\"All three analyses at once\"\"\"\n",
    "    response = requests.post(\n",
    "        f\"{BASE_URL_FASTAPI}/analyze/all\",\n",
    "        json={\"health_data\": health_data}\n",
    "    )\n",
    "    return response.json()\n",
    "\n",
    "print(\"API wrapper functions loaded:\")\n",
    "print(\"- analyze_simple(health_data)\")\n",
    "print(\"- analyze_parallel(health_data)\")\n",
    "print(\"- analyze_sequential(health_data)\")\n",
    "print(\"- analyze_all(health_data)\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "c6c92396",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Simple analysis result:\n",
      "{\n",
      "  \"status\": \"success\",\n",
      "  \"data\": {\n",
      "    \"state\": {},\n",
      "    \"user_id\": \"api_user\",\n",
      "    \"session_id\": \"s_cb66b27a\"\n",
      "  },\n",
      "  \"message\": \"Simple prescription analysis completed successfully\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "# Test with first patient\n",
    "if inputs_to_llm:\n",
    "    patient_data = inputs_to_llm[2]\n",
    "    \n",
    "    # Test simple analysis\n",
    "    result = analyze_simple(patient_data)\n",
    "    print(\"Simple analysis result:\")\n",
    "    print(json.dumps(result, indent=2))\n",
    "else:\n",
    "    print(\"No patient data available for testing\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "791a18b4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paralell analysis result:\n",
      "{\n",
      "  \"status\": \"success\",\n",
      "  \"data\": {\n",
      "    \"state\": {},\n",
      "    \"user_id\": \"api_user\",\n",
      "    \"session_id\": \"s_9c0180fd\",\n",
      "    \"dose_drug_analysis\": \"The current prescription is for Carbidopa-Levodopa 1800-3600 mcg in the right eye, which is not a standard route of administration, raising serious concerns. HIGH\",\n",
      "    \"route_drug_analysis\": \"The route \\\"RIGHT EYE\\\" for Carbidopa-Levodopa is not a standard or safe route of administration. This route is highly unusual and could be harmful.\\nGrading: HIGH\",\n",
      "    \"drug_analysis\": \"The provided prescription is for 'Carbidopa-Levodopa (10-100)'. This medication is usually administered orally for Parkinson's disease, and the current prescription indicates a route of administration as 'RIGHT EYE' with a dose of '1800-3600 mcg'.\\n\\nGiven the unusual route of administration ('RIGHT EYE') for Carbidopa-Levodopa, this raises a HIGH safety concern. This medication is not typically administered via the eye, and this route may be an error.\",\n",
      "    \"synthesized_results_criticality\": {\n",
      "      \"level_drug\": \"HIGH\",\n",
      "      \"level_dose\": \"HIGH\",\n",
      "      \"level_route\": \"HIGH\",\n",
      "      \"description\": \"All three specialist agents (drug_analysis, dose_analysis, and route_analysis) independently flagged the 'RIGHT EYE' route of administration for Carbidopa-Levodopa as a HIGH safety concern. This medication is typically administered orally for Parkinson's disease, making the prescribed route highly unusual, potentially erroneous, and potentially harmful. The convergence of these concerns warrants immediate attention and verification with the prescribing physician.\"\n",
      "    }\n",
      "  },\n",
      "  \"message\": \"Parallel prescription analysis completed successfully\"\n",
      "}\n"
     ]
    }
   ],
   "source": [
    "# Test with first patient\n",
    "if inputs_to_llm:\n",
    "    patient_data = inputs_to_llm[2]\n",
    "    \n",
    "    # Test simple analysis\n",
    "    result = analyze_parallel(patient_data)\n",
    "    print(\"Paralell analysis result:\")\n",
    "    print(json.dumps(result, indent=2))\n",
    "else:\n",
    "    print(\"No patient data available for testing\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "b8cced12",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Analyzing patients: 100%|██████████| 10/10 [00:29<00:00,  3.00s/it]\n"
     ]
    }
   ],
   "source": [
    "from tqdm import tqdm \n",
    "\n",
    "outputs = []\n",
    "for patient_data in tqdm(inputs_to_llm, desc=\"Analyzing patients\"):\n",
    "    result = analyze_parallel(patient_data)\n",
    "    outputs.append(result)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "8580d2a2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_7d7eb6d4',\n",
       "   'drug_analysis': \"The current prescription is MethylPREDNISolone Sodium Succinate. High doses of methylprednisolone, especially via subcutaneous administration, may present a risk of systemic side effects; however, this falls within the prescriber's judgment.\\n\",\n",
       "   'dose_drug_analysis': 'The prescribed dose of MethylPREDNISolone Sodium Succ (1500-2900 mg SC) is extremely high, and potentially dangerous, exceeding typical single doses. HIGH',\n",
       "   'route_drug_analysis': 'The subcutaneous route (SC) is not a standard route for methylprednisolone sodium succinate, especially at high doses (1500-2900mg). This could lead to unpredictable absorption and potential local tissue reactions, making this a HIGH risk.',\n",
       "   'synthesized_results_criticality': {'level_drug': 'MEDIUM',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': \"The Drug Safety agent flagged the potential for systemic side effects at high doses, but deferred to the prescriber's judgment. However, both the Dosing Safety and Route Safety agents identified HIGH risks. The extremely high dose (1500-2900mg) via the subcutaneous route is non-standard and dangerous, raising serious concerns about unpredictable absorption and local tissue reactions. Given the converging HIGH risk flags on dose and route, I am escalating this to a HIGH overall concern requiring immediate attention.\"}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_2316b6e2',\n",
       "   'drug_analysis': 'HIGH. There is a critical medication error. Mycophenolate Mofetil 3000 Enema orally is not a standard or safe route/formulation. Mycophenolate Mofetil is an immunosuppressant and this prescription needs immediate review.',\n",
       "   'dose_drug_analysis': 'The prescription is for \"Mycophenolate Mofetil 3000 Enema ORAL\". This route (ORAL) and form (Enema) combination is highly unusual and likely an error, but the available information is insufficient to assess dosing safety. Grade: LOW.',\n",
       "   'route_drug_analysis': 'HIGH. Mycophenolate mofetil is not typically administered via enema, and giving the full oral dose as an enema could lead to unpredictable absorption and potential toxicity due to the altered route of administration. This route deviates significantly from standard use and could pose a safety risk.',\n",
       "   'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "    'level_dose': 'LOW',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': 'The prescription for Mycophenolate Mofetil 3000 Enema orally presents a critical safety concern. Both the Drug Safety and Route Safety agents flagged this as HIGH risk due to the highly unusual and unsafe combination of enema formulation administered orally. Mycophenolate Mofetil is an immunosuppressant, and this unconventional route/formulation warrants immediate review to prevent potential toxicity and ensure patient safety. The dosing agent flagged this as LOW but did mention that the combination of route and form is highly unusual.'}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_c4c39d19',\n",
       "   'dose_drug_analysis': 'The drug Carbidopa-Levodopa is not typically administered via the RIGHT EYE route. This prescription should be verified for appropriateness, especially given the unusual route. HIGH',\n",
       "   'route_drug_analysis': 'The route \"RIGHT EYE\" for Carbidopa-Levodopa is highly unusual and potentially inappropriate. Carbidopa-Levodopa is not typically administered via the ophthalmic route; this warrants immediate verification with the prescriber to avoid potential harm. GRADE: HIGH',\n",
       "   'drug_analysis': 'There appears to be an error in the current prescription, as Carbidopa-Levodopa is not administered via the ocular route (RIGHT EYE). This could represent a medication error requiring clarification. GRADE: HIGH.',\n",
       "   'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': 'All three agents (Drug Safety, Dosing Safety, and Route Safety) independently flagged the administration of Carbidopa-Levodopa via the RIGHT EYE route as highly inappropriate and potentially a medication error. This convergence strongly suggests an immediate safety concern requiring urgent verification with the prescriber. The usual routes of administration for this medication do not include ophthalmic use.'}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_2072c1d5',\n",
       "   'drug_analysis': 'Rituximab is not in the provided prescription list. There seems to be an error, and I cannot proceed.',\n",
       "   'route_drug_analysis': 'HIGH. The \"OU\" route indicates administration in both eyes, which is not an approved route for Rituximab, and could lead to serious harm.',\n",
       "   'dose_drug_analysis': 'I am sorry, but I cannot assess the safety of Rituximab, as it is not in the provided context.\\n',\n",
       "   'synthesized_results_criticality': {'level_drug': 'LOW',\n",
       "    'level_dose': 'LOW',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': \"Rituximab is not in the patient's active medication list, raising an initial flag. However, the PRIMARY safety concern is the 'OU' (both eyes) route, which is not an approved administration method for Rituximab and presents a high risk of serious harm. While the drug and dose safety could not be fully assessed due to the missing drug context, the inappropriate route necessitates immediate intervention.\"}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_ea19d5f4',\n",
       "   'route_drug_analysis': \"The route 'NU' is not a standard route of administration and is therefore HIGH risk. This could lead to incorrect administration and potential harm to the patient.\",\n",
       "   'drug_analysis': 'The provided prescription is for Nafcillin, but the dose unit \"AMP\" is highly unusual and could represent a medication error. This requires verification to ensure correct drug and dose are administered. GRADE: HIGH',\n",
       "   'dose_drug_analysis': 'I am unable to evaluate the safety of this dose as the units are \"AMP\" and the route is \"NU,\" which do not provide enough information. I can not assess the dose without a valid unit of measurement.',\n",
       "   'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': \"Nafcillin is prescribed with a highly unusual dose unit 'AMP' and a non-standard route 'NU'. Both the drug analysis and route analysis agents flagged these as HIGH risk, indicating a strong possibility of medication error and/or incorrect administration. The dose agent was unable to assess safety due to the invalid units and route. This combination of factors necessitates immediate verification and correction to avoid potential harm.\"}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_59843cc2',\n",
       "   'route_drug_analysis': 'HIGH. Ciprofloxacin is not available as an enema, and oral administration for a drug intended to be an enema would result in incorrect dosing and therapeutic failure for the intended purpose.',\n",
       "   'dose_drug_analysis': 'The prescription is for Ciprofloxacin 98 Enema PO. Ciprofloxacin is not typically administered as an enema, and this is likely an error, especially considering the PO route. GRADE: HIGH',\n",
       "   'drug_analysis': 'The current prescription is for Ciprofloxacin. There is a significant risk of medication error due to the potential for look-alike/sound-alike confusion with CeftriaXONE already prescribed; this requires verification. GRADE: MEDIUM',\n",
       "   'synthesized_results_criticality': {'level_drug': 'MEDIUM',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': \"The prescription for Ciprofloxacin 98 Enema PO presents a HIGH risk. There are convergent and compounding safety concerns: Ciprofloxacin is being prescribed, which may be confused with CeftriaXONE, a medication the patient is already receiving. Ciprofloxacin is not available as an enema formulation. Prescribing it orally when it's written as 'Enema' will result in therapeutic failure and incorrect dosing. The unusual dose ('98 Enema') and route (PO) strongly suggest a prescription error requiring urgent clarification and correction.\"}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_d40d89d2',\n",
       "   'dose_drug_analysis': 'The prescription is for Mycophenolate Mofetil 3000 Enema ORAL, which is an unusual route and dose for this medication. This route and form are not standard for Mycophenolate Mofetil and the dose is extremely high and potentially dangerous. HIGH',\n",
       "   'route_drug_analysis': 'The prescription is for Mycophenolate Mofetil 3000 Enema ORAL. Giving an enema orally is an inappropriate route of administration. HIGH',\n",
       "   'drug_analysis': \"HIGH: Mycophenolate Mofetil has a black box warning for increased risk of infection and malignancy. This drug requires careful monitoring and is contraindicated in patients with known hypersensitivity. Additionally, there's a potential medication error, as Mycophenolate Mofetil is not typically administered via enema; the route is usually oral or IV, which needs verification.\",\n",
       "   'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': 'Mycophenolate Mofetil is a high-risk medication. The prescribed route (oral enema) is inappropriate and the dose is extremely high. These factors, in combination with the inherent risks of the drug, necessitate immediate intervention to clarify the prescription with the prescribing physician and ensure patient safety. The confluence of HIGH flags across all categories indicates a critical situation.'}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_12728458',\n",
       "   'drug_analysis': 'The current prescription is Mycophenolate Mofetil. Mycophenolate Mofetil has a black box warning for increased risk of infection and malignancy; monitoring and awareness of these risks are important. GRADE: MEDIUM',\n",
       "   'dose_drug_analysis': 'The route of administration for Mycophenolate Mofetil is listed as ORAL, but the dose is given in Enemas, which is an inconsistency that should be clarified. This raises a HIGH safety concern due to the implausibility of the prescribed route.',\n",
       "   'route_drug_analysis': 'HIGH: Oral administration of mycophenolate mofetil as an enema (3000 Enema) is an inappropriate route and could lead to therapeutic failure; mycophenolate mofetil is typically administered orally or intravenously. The dose is also unusually high.',\n",
       "   'synthesized_results_criticality': {'level_drug': 'MEDIUM',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': 'The oral administration of mycophenolate mofetil with a dose of 3000 enemas is highly concerning due to the implausible route and unusually high dose. This discrepancy between route and dose unit, coupled with the black box warning for infection and malignancy, creates a critical safety issue. Immediate clarification with the prescribing physician is needed to ensure appropriate administration and patient safety.'}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_30226827',\n",
       "   'route_drug_analysis': 'The route DIALYS is HIGH risk. Bacitracin is not typically administered via dialysis, and this route could lead to unpredictable drug exposure and potential complications.',\n",
       "   'dose_drug_analysis': \"I am sorry, I cannot fulfill the request. The current prescription is for 'Bacitracin Ointment' at 700 doses via DIALYS, which is not present in the provided list of prescriptions. Can you provide me with a prescription from the provided list?\\n\",\n",
       "   'drug_analysis': 'Bacitracin ointment is generally safe for topical use but is not typically administered via dialysis (DIALYS). This unusual route of administration warrants further clarification to ensure appropriate use and to prevent potential complications. GRADE: MEDIUM',\n",
       "   'synthesized_results_criticality': {'level_drug': 'MEDIUM',\n",
       "    'level_dose': 'MEDIUM',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': 'The intended route of administration (DIALYS) for Bacitracin ointment is HIGH risk, as confirmed by the route safety analysis. The drug safety agent also flagged the DIALYS route as non-standard and potentially problematic. The dose agent could not validate the prescribed amount, further contributing to the overall concern. Given the convergence of these issues, the final assessment points to a significant safety risk requiring immediate clarification from the prescribing physician. A deviation from standard topical use to dialysis administration presents serious potential complications.'}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'},\n",
       " {'status': 'success',\n",
       "  'data': {'state': {},\n",
       "   'user_id': 'api_user',\n",
       "   'session_id': 's_13dbf760',\n",
       "   'drug_analysis': 'The current prescription is for Fentanyl Patch. HIGH: Fentanyl is a high-risk medication, particularly due to its potential for respiratory depression and risk of misuse; this warrants careful monitoring, especially given the multiple other medications prescribed.',\n",
       "   'dose_drug_analysis': \"The medication is 'Fentanyl Patch' with a dose of 225 PUFFS via DWELL. This route and unit seem highly irregular for fentanyl, and the dose is unusually high, raising serious concerns about a potential error. GRADE: HIGH\",\n",
       "   'route_drug_analysis': 'The route \"DWELL\" for Fentanyl Patch is unclear and potentially inappropriate; fentanyl patches are typically administered transdermally, and \"DWELL\" doesn\\'t align with standard routes, raising a HIGH safety concern. This requires immediate clarification.',\n",
       "   'synthesized_results_criticality': {'level_drug': 'HIGH',\n",
       "    'level_dose': 'HIGH',\n",
       "    'level_route': 'HIGH',\n",
       "    'description': \"The prescription for Fentanyl Patch presents a high safety risk due to the inherent dangers of fentanyl (respiratory depression, misuse potential) compounded by a highly unusual and potentially erroneous dose ('225 PUFFS') and route ('DWELL'). The combination of these factors necessitates immediate clarification and correction to ensure patient safety. The dose and route raise serious concerns that this is an error.\"}},\n",
       "  'message': 'Parallel prescription analysis completed successfully'}]"
      ]
     },
     "execution_count": 80,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "outputs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "574e1f34",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "81aeee06",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "language_info": {
   "name": "python"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
